24-556 Phase III
A Phase 3, Randomized, Open-Label Study to Compare the Efficacy and Safety of anitocabtagene autoleucel (anito-cel) versus Standard of Care Therapy in Participants with Relapsed/Refractory Multiple Myeloma (iMMagine-3)
Search Cancer Clinical Trials
Mass General Cancer Center offers patients access to a wide variety of clinical trials of promising new therapies. Use the search tool to find open protocols for your type of cancer.
15 results
20-518 Phase I
A Phase I Clinical Trial with TriPRIL CAR T Cells for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma
23-183 Phase II
A phase II study of ISABELA: isatuximab, belantamab mafodotin, pomalidomide, and dexamethasone in relapsed and refractory multiple myeloma
17-336 N/A
Clinical-grade Molecular Profiling of Patients with Multiple Myeloma and Related Plasma Cell Malignancies
21-439 Phase II
Phase II study on Acalabrutinib and anti-CD20 antibody in Patients with Anti-MAG Mediated Neuropathy
Showing 11 - 15 of 15 results